Does hepatic vein transit time performed with contrast-enhanced ultrasound predict the severity of hepatic fibrosis?

Ultrasound in Medicine and Biology

Volumn 37, Issue 12, 2011, Pages 1963-1969

  Tang, An ^a,d   Kim, Tae Kyoung ^a   Heathcote, Jenny ^b   Guindi, Maha ^a   Jang, Hyun Jung ^a   Karshafian, Raffi ^c   Burns, Peter N ^c   Wilson, Stephanie R ^a,e  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

Blood flow; Contrast agent; Contrast ultrasound; Hepatic transit time; Liver; Noninvasive measure of liver fibrosis; Quantitative analysis

Indexed keywords

BLOOD FLOW; CONTRAST AGENT; CONTRAST ULTRASOUND; NONINVASIVE MEASURE OF LIVER FIBROSIS; TRANSIT TIME;

CHEMICAL ANALYSIS; LIVER; RADIOLOGY;

ULTRASONICS;

ADULT; AGED; ARTICLE; BLOOD VESSEL PARAMETERS; CARDIOPULMONARY HEMODYNAMICS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEMODYNAMIC MONITORING; HEPATIC VEIN TRANSIT TIME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CIRCULATION; LIVER FIBROSIS; MALE; PREDICTION; PRIORITY JOURNAL; REAL TIME ECHOGRAPHY; RETICULOENDOTHELIAL SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ADULT; AGED; COMPUTER SIMULATION; CONTRAST MEDIA; FEMALE; FLUOROCARBONS; HEPATIC VEINS; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER CIRRHOSIS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY;

EID: 82955187786     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2011.09.010     Document Type: Article

References (21)

1. Albrecht T., Blomley M.J., Cosgrove D.O., Taylor-Robinson S.D., Jayaram V., Eckersley R., Urbank A., Butler-Barnes J., Patel N. Noninvasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 1999, 353:1579-1583.
2. Bang N., Nielsen M.B., Rasmussen A.N., Osterhammel P.A., Pedersen J.F. Hepatic vein transit time of an ultrasound contrast agent: Simplified procedure using pulse inversion imaging. Br J Radiol 2001, 74:752-755.
3. Blanc J.F., Bioulac-Sage P., Balabaud C., Desmouliere A. Investigation of liver fibrosis in clinical practice. Hepatol Res 2005, 32:1-8.
4. Blomley M.J., Lim A.K., Harvey C.J., Patel N., Eckersley R.J., Basilico R., Heckemann R., Urbank A., Cosgrove D.O., Taylor-Robinson S.D. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: A cross- sectional study. Gut 2003, 52:1188-1193.
5. Burns P.N., Wilson S.R., Simpson D.H. Pulse inversion imaging of liver blood flow: Improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000, 35:58-71.
6. Cadranel J.F., Rufat P., Degos F. Practices of liver biopsy in France: Results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000, 32:477-481.
7. Giuseppetti G.M., Argalia G., Abbattista T. Liver cirrhosis: Evaluation of haemodynamic changes using an ultrasound contrast agent. Eur J Radiol 2004, 51:27-33.
8. Iijima H., Moriyasu F., Miyahara T., Yanagisawa K. Ultrasound contrast agent, Levovist microbubbles are phagocytosed by Kupffer cells-In vitro and in vivo studies. Hepatol Res 2006, 35:235-237.
9. Kono Y., Steinbach G.C., Peterson T., Schmid-Schonbein G.W., Mattrey R.F. Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: An intravital microscopy study in rats. Radiology 2002, 224:253-257.
10. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
11. Lim A.K., Patel N., Eckersley R.J., Goldin R.D., Thomas H.C., Cosgrove D.O., Taylor-Robinson S.D., Blomley M.J. Hepatic vein transit time of SonoVue: A comparative study with Levovist. Radiology 2006, 240:130-135.
12. Lim A.K., Taylor-Robinson S.D., Patel N., Eckersley R.J., Goldin R.D., Hamilton G., Foster G.R., Thomas H.C., Cosgrove D.O., Blomley M.J. Hepatic vein transit times using a microbubble agent can predict disease severity noninvasively in patients with hepatitis C. Gut 2005, 54:128-133.
13. Maruyama H., Matsutani S., Saisho H., Mine Y., Yuki H., Miyata K. Different behaviors of microbubbles in the liver: Time-related quantitative analysis of two ultrasound contrast agents, Levovist and Definity. Ultrasound Med Biol 2004, 30:1035-1040.
14. Matsumura M., Bevan P., Lindvere L., Karshafian R., Wang F.-M., Iijima H., et al. Do different factors determine the in vivo and in vitro longevity of perfluorocarbon contrast agents? Ninth European Symposium on Ultrasound Contrast Imaging 2004, Erasmus University, Rotterdam.
15. Pedersen J.F., Larsen V.A., Bytzer P., Madsen L.G., Hamberg O. Hepatic transit time of ultrasound contrast in biopsy characterized liver disease. Acta Radiol 2005, 46:557-560.
16. Poynard T., Mathurin P., Lai C.L., Guyader D., Poupon R., Tainturier M.H., Myers R.P., Muntenau M., Ratziu V., Manns M., Vogel A., Capron F., Chedid A., Bedossa P. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003, 38:257-265.
17. Ridolfi F., Abbattista T., Marini F., Vedovelli A., Quagliarini P., Busilacchi P., Brunelli E. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C. Dig Liver Dis 2007, 39:929-935.
18. Staub F., Tournoux-Facon C., Roumy J., Chaigneau C., Morichaut-Beauchant M., Levillain P., Prevost C., Aube C., Lebigot J., Oberti F., Galtier J.B., Laumonier H., Trillaud H., Bernard P.H., Blanc J.F., Sironneau S., Machet F., Drouillard J., de Ledinghen V., Couzigou P., Foucher P., Castera L., Tranquard F., Bacq Y., d'Alteroche L., Ingrand P., Tasu J.P. Liver fibrosis staging with contrast-enhanced ultrasonography: Prospective multicenter study compared with METAVIR scoring. Eur Radiol 2009, 19:1991-1997.
19. Sugimoto H., Kaneko T., Hirota M., Tezel E., Nakao A. Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. J Hepatol 2002, 37:578-583.
20. Villeneuve J.P., Dagenais M., Huet P.M., Roy A., Lapointe R., Marleau D. The hepatic microcirculation in the isolated perfused human liver. Hepatology 1996, 23:24-31.
21. Yanagisawa K., Moriyasu F., Miyahara T., Yuki M., Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biology 2007, 33:318-325.